Physician profile
Anna Knight
NPI 1972846632
$1,003.62
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2021: $185 · 2022: $82.03 · 2023: $370 · 2024: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562 · Education: $72.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.29 |
| Education | $72.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $458.50 | 2021-2024 | Myrisk, Bracanalysis Cdx |
| Kub Technologies INC. | $138.45 | 2024 | |
| Merck Sharp & Dohme LLC | $102.00 | 2019 | |
| Gilead Sciences, INC. | $72.73 | 2023 | Trodelvy |
| Leica Microsystems INC. | $65.66 | 2023 | Neoprobe |
| Hologic Sales and Service, LLC | $44.56 | 2023-2024 | Trident Specimen Radiography System, Sertera Biopsy Device |
| Medtronic, INC. | $32.28 | 2023 | Ligasure |
| Sirius Medical Systems | $24.53 | 2024 | Pintuition |
| Glaxosmithkline, LLC. | $24.06 | 2022 | |
| Impedimed, INC. | $21.58 | 2024 | |
| Tactile Systems Technology INC | $19.27 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Knight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.